Correction: Bortezomib Treatment Sensitizes Oncolytic HSV-1-Treated Tumors to NK Cell Immunotherapy. [electronic resource]
Publication details: Clinical cancer research : an official journal of the American Association for Cancer Research 03 2017Description: 1359-1360 p. digitalISSN:- 1557-3265
No physical items for this record
Publication Type: Journal Article; Published Erratum
There are no comments on this title.
Log in to your account to post a comment.